BofA Securities Upgrades Rhythm Pharmaceuticals (RYTM) to Buy 'on valuation and lower risk'
Tweet Send to a Friend
(Updated - April 7, 2025 12:16 PM EDT)
BofA Securities analyst Tazeen Ahmad upgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad upgraded Rhythm Pharmaceuticals (NASDAQ: RYTM) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
